Michael Silber – Page 179

Kentucky

The BOP has withdrawn its recent regulation 201 KAR 2:410E expanding pharmacies immunization authority and replaced it with an emergency revised regulation that includes the most recent HHS Guidance allowing pharmacy technicians to administer influenza vaccines to adults. The regulation maintains the ability of any pharmacist to order and administer vaccinations for anyone over the age of three years old, under a protocol. The regulation will next be reviewed by the Administrative Regulatory Review Subcommittee of the General Assembly. However, because it was filed as an emergency regulation, it is in effect now.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Michael Silber2021-09-03T08:48:35-04:00September 3, 2021|Kentucky|

Maryland

Medicaid published Advisory #231 from the Office of Pharmacy Services in reference to the Pharmacy Provider Guidance on COVID-19 Additional Vaccine Dose for The Maryland Medicaid Fee-for-Service (FFS) Program.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Michael Silber2021-09-03T08:48:02-04:00September 3, 2021|Maryland|

Michigan

The Michigan Department of Health and Human Services has scheduled a Medicaid Pharmacy Provider Liaison meeting to allow Medicaid staff and Medicaid Pharmacy Providers to meet and discuss policy and operational issues. This quarter’s Pharmacy Liaison Meeting Notice contains the link and phone number to join, and will take place Thursday, September 9th from 2:30-4:30pm.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

Michael Silber2021-09-03T08:47:03-04:00September 3, 2021|Michigan|

Nebraska

The Department of Health and Human Services announced the COVID-19 Ad-Hoc Schedule 3rd Dose Vaccine Update.  Effective date was August 12, 2021. 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

Michael Silber2021-09-03T08:46:18-04:00September 3, 2021|Nebraska|

New Mexico

Below are highlights from the September issue of the Board of Pharmacy newsletter. See the newsletter for additional details and more information.  

HIV Post-Exposure Prophylaxis and Point-of-Care Testing: Pharmacist prescriptive authority for the prescribing of HIV post-exposure prophylaxis therapy in conjunction with point-of-care testing was approved by the Board during its April 2021 meeting. Pharmacists who wish to obtain this prescriptive authority must go through Board-approved training and adhere to the Board-approved protocol.
Regulation Updates
- 16.19.4 NMAC – Medical cannabis
- 16.19.20 NMAC – Changes to the scheduling status of certain substances
- 16.19.30 NMAC – Changes to the compounding of nonsterile pharmaceuticals.
- 16.19.31 NMAC – Emergency Provisions adding a section outlining Board authority to authorize extensions for unavailable training or testing during a declared emergency. This includes pharmacist license under reciprocity, technician registration, or pharmacist prescriptive authority.

2021 Law Update Schedule

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

Michael Silber2021-09-03T08:45:39-04:00September 3, 2021|New Mexico|

New York

Senator Bradley Hoylman (D) introduced S 7320 legislation which would expand pharmacists’ authority to administer COVID immunizations down to age two. No hearing has been scheduled yet.

Also in New York, the NYS Department of Health held a webinar to update the pharmacy stakeholders on implementation of a single statewide formulary for opioid dependence agents and opioid antagonists effective October 1, 2021. The full presentation will be available on the Department of Health Website within the week. The Department of Health highlighted that a single formulary would provide consistent same rules for all Medicaid programs both FFS and MC for these categories of drugs.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

Michael Silber2021-09-03T08:44:00-04:00September 3, 2021|New York|

Pennsylvania

The Governor’s Opioid Command Center in conjunction with the Department of Drug and Alcohol Programs have announced their intent to implement the Naloxone Copay Assistance Program on Oct. 1, 2021. Any PACE provider may submit claims to the new Naloxone Copay Assistance Program for up to $75 per claim for any Commonwealth resident (does not have to be a PACE beneficiary) through the existing PACE adjudication system. Additional program details will be provided in the next 2 weeks. The program is a result of a partnership between the state and NACDS and Pennsylvania Association of Chain Drug Stores (PACDS). We are currently working with members and the PACE program to develop the patient criteria and operationalize the program.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Michael Silber2021-09-03T08:43:24-04:00September 3, 2021|Pennsylvania|

Tennessee

The Tennessee Pharmacy Association has produced a flowchart to help guide pharmacists through the process of filing complaints when PBMs are not following the new law. This flowchart was developed after hearing from the Tennessee Department of Commerce and Insurance (TDCI) that they are receiving incomplete claims, claims that still need to go through the MAC Appeal Process, or claims for Medicare, over which TDCI has no jurisdiction. This will be the first in a series of educational materials that TPA will provide in the coming weeks.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

Michael Silber2021-09-03T08:42:48-04:00September 3, 2021|Tennessee|

Alabama

After further review, the Agency will not resume the EPSDT referral requirement as referenced in the July 27, 2021 Provider ALERT. This allowance will continue through the conclusion of the COVID-19 national emergency, or any expiration date noticed by the Alabama Medicaid Agency through a subsequent ALERT.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

Michael Silber2021-08-27T12:44:38-04:00August 27, 2021|Alabama|

About Michael Silber